Serum Levels of Soluble Interleukin–2 Receptor at Acute Asthma Exacerbation: Relationship with Severity of Exacerbation and Bronchodilator Response | Citedby Results | International Archives of Allergy and Immunology | Karger Publishers

Skip to Main Content

Skip Nav Destination

Serum Levels of Soluble Interleukin–2 Receptor at Acute Asthma Exacerbation: Relationship with Severity of Exacerbation and Bronchodilator Response

Int Arch Allergy Immunol (1998) 117 (4): 263–269.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Use of biologicals as immunotherapy in asthma and related diseases

Brandie L Walker
Richard Leigh

Expert Review of Clinical Immunology (2008) 4 (6): 743.

T cell and eosinophil activation in mild and moderate atopic and nonatopic children's asthma in remission

I. Pumputiene
R. Emuzyte
R. Dubakiene
R. Firantiene
V. Tamosiunas

Allergy (2006) 61 (1): 43.

Differentiation of chronic sinus diseases by measurement of inflammatory mediators

T. Van Zele
S. Claeys
P. Gevaert
G. Van Maele
G. Holtappels
P. Van Cauwenberge
C. Bachert

Allergy (2006) 61 (11): 1280.

Measurement of Inflammatory Mediators of Eosinophils and Lymphocytes in Blood in Acute Asthma: Serum Levels of ECP Influence the Bronchodilator Response

Gabriele Di Lorenzo
Maria Luisa Pacor
Giuseppina Morici
Agata Drago
Maria Esposito-Pellitteri
Giuseppina Candore
Claudia Lo Bianco
Calogero Caruso

International Archives of Allergy and Immunology (2002) 127 (4): 308.